Global Sustained Release Ocular Drug Delivery Systems Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sustained Release Ocular Drug Delivery Systems Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Sustained Release Ocular Drug Delivery Systems by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Sustained Release Ocular Drug Delivery Systems by Country/Region, 2017, 2022 & 2028

2.2 Sustained Release Ocular Drug Delivery Systems Segment by Type

2.2.1 Liposome

2.2.2 Microcapsules/Nanocapsules

2.2.3 Microspheres/Nanosptheres

2.2.4 Implants

2.3 Sustained Release Ocular Drug Delivery Systems Sales by Type

2.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2022)

2.3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Type (2017-2022)

2.3.3 Global Sustained Release Ocular Drug Delivery Systems Sale Price by Type (2017-2022)

2.4 Sustained Release Ocular Drug Delivery Systems Segment by Application

2.4.1 Cataract

2.4.2 Glaucoma

2.4.3 Corneal Transplantation

2.4.4 Others

2.5 Sustained Release Ocular Drug Delivery Systems Sales by Application

2.5.1 Global Sustained Release Ocular Drug Delivery Systems Sale Market Share by Application (2017-2022)

2.5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Application (2017-2022)

2.5.3 Global Sustained Release Ocular Drug Delivery Systems Sale Price by Application (2017-2022)

3 Global Sustained Release Ocular Drug Delivery Systems by Company

3.1 Global Sustained Release Ocular Drug Delivery Systems Breakdown Data by Company

3.1.1 Global Sustained Release Ocular Drug Delivery Systems Annual Sales by Company (2020-2022)

3.1.2 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2020-2022)

3.2 Global Sustained Release Ocular Drug Delivery Systems Annual Revenue by Company (2020-2022)

3.2.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Company (2020-2022)

3.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Company (2020-2022)

3.3 Global Sustained Release Ocular Drug Delivery Systems Sale Price by Company

3.4 Key Manufacturers Sustained Release Ocular Drug Delivery Systems Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Location Distribution

3.4.2 Players Sustained Release Ocular Drug Delivery Systems Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Sustained Release Ocular Drug Delivery Systems by Geographic Region

4.1 World Historic Sustained Release Ocular Drug Delivery Systems Market Size by Geographic Region (2017-2022)

4.1.1 Global Sustained Release Ocular Drug Delivery Systems Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Sustained Release Ocular Drug Delivery Systems Annual Revenue by Geographic Region

4.2 World Historic Sustained Release Ocular Drug Delivery Systems Market Size by Country/Region (2017-2022)

4.2.1 Global Sustained Release Ocular Drug Delivery Systems Annual Sales by Country/Region (2017-2022)

4.2.2 Global Sustained Release Ocular Drug Delivery Systems Annual Revenue by Country/Region

4.3 Americas Sustained Release Ocular Drug Delivery Systems Sales Growth

4.4 APAC Sustained Release Ocular Drug Delivery Systems Sales Growth

4.5 Europe Sustained Release Ocular Drug Delivery Systems Sales Growth

4.6 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Growth

5 Americas

5.1 Americas Sustained Release Ocular Drug Delivery Systems Sales by Country

5.1.1 Americas Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022)

5.1.2 Americas Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022)

5.2 Americas Sustained Release Ocular Drug Delivery Systems Sales by Type

5.3 Americas Sustained Release Ocular Drug Delivery Systems Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sustained Release Ocular Drug Delivery Systems Sales by Region

6.1.1 APAC Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022)

6.1.2 APAC Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022)

6.2 APAC Sustained Release Ocular Drug Delivery Systems Sales by Type

6.3 APAC Sustained Release Ocular Drug Delivery Systems Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Sustained Release Ocular Drug Delivery Systems by Country

7.1.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022)

7.1.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022)

7.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Type

7.3 Europe Sustained Release Ocular Drug Delivery Systems Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sustained Release Ocular Drug Delivery Systems by Country

8.1.1 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022)

8.1.2 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022)

8.2 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Type

8.3 Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Sustained Release Ocular Drug Delivery Systems

10.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems

10.4 Industry Chain Structure of Sustained Release Ocular Drug Delivery Systems

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Sustained Release Ocular Drug Delivery Systems Distributors

11.3 Sustained Release Ocular Drug Delivery Systems Customer

12 World Forecast Review for Sustained Release Ocular Drug Delivery Systems by Geographic Region

12.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Region

12.1.1 Global Sustained Release Ocular Drug Delivery Systems Forecast by Region (2023-2028)

12.1.2 Global Sustained Release Ocular Drug Delivery Systems Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Sustained Release Ocular Drug Delivery Systems Forecast by Type

12.7 Global Sustained Release Ocular Drug Delivery Systems Forecast by Application

13 Key Players Analysis

13.1 pSivida

13.1.1 pSivida Company Information

13.1.2 pSivida Sustained Release Ocular Drug Delivery Systems Product Offered

13.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 pSivida Main Business Overview

13.1.5 pSivida Latest Developments

13.2 Allergan

13.2.1 Allergan Company Information

13.2.2 Allergan Sustained Release Ocular Drug Delivery Systems Product Offered

13.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Allergan Main Business Overview

13.2.5 Allergan Latest Developments

13.3 Icon Bioscience

13.3.1 Icon Bioscience Company Information

13.3.2 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Offered

13.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Icon Bioscience Main Business Overview

13.3.5 Icon Bioscience Latest Developments

13.4 Ocular Therapeutix

13.4.1 Ocular Therapeutix Company Information

13.4.2 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Offered

13.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ocular Therapeutix Main Business Overview

13.4.5 Ocular Therapeutix Latest Developments

13.5 Neurotech Pharmaceuticals

13.5.1 Neurotech Pharmaceuticals Company Information

13.5.2 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offered

13.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Neurotech Pharmaceuticals Main Business Overview

13.5.5 Neurotech Pharmaceuticals Latest Developments

13.6 Santen Pharmaceutical

13.6.1 Santen Pharmaceutical Company Information

13.6.2 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Offered

13.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Santen Pharmaceutical Main Business Overview

13.6.5 Santen Pharmaceutical Latest Developments

13.7 Aciont Inc.

13.7.1 Aciont Inc. Company Information

13.7.2 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Offered

13.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Aciont Inc. Main Business Overview

13.7.5 Aciont Inc. Latest Developments

13.8 Envisia Therapeutics

13.8.1 Envisia Therapeutics Company Information

13.8.2 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Offered

13.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Envisia Therapeutics Main Business Overview

13.8.5 Envisia Therapeutics Latest Developments

13.9 GrayBug

13.9.1 GrayBug Company Information

13.9.2 GrayBug Sustained Release Ocular Drug Delivery Systems Product Offered

13.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GrayBug Main Business Overview

13.9.5 GrayBug Latest Developments

13.10 Innocore Pharmaceuticals

13.10.1 Innocore Pharmaceuticals Company Information

13.10.2 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offered

13.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Innocore Pharmaceuticals Main Business Overview

13.10.5 Innocore Pharmaceuticals Latest Developments

13.11 OHR Pharmaceuticals

13.11.1 OHR Pharmaceuticals Company Information

13.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offered

13.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 OHR Pharmaceuticals Main Business Overview

13.11.5 OHR Pharmaceuticals Latest Developments

13.12 PolyActiva

13.12.1 PolyActiva Company Information

13.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Product Offered

13.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 PolyActiva Main Business Overview

13.12.5 PolyActiva Latest Developments

13.13 TheraKine

13.13.1 TheraKine Company Information

13.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Product Offered

13.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 TheraKine Main Business Overview

13.13.5 TheraKine Latest Developments

14 Research Findings and Conclusion

Table 1. Sustained Release Ocular Drug Delivery Systems Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Sustained Release Ocular Drug Delivery Systems Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Liposome

Table 4. Major Players of Microcapsules/Nanocapsules

Table 5. Major Players of Microspheres/Nanosptheres

Table 6. Major Players of Implants

Table 7. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2022)

Table 9. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & ($ million)

Table 10. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2017-2022)

Table 11. Global Sustained Release Ocular Drug Delivery Systems Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2022)

Table 14. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022)

Table 15. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2017-2022)

Table 16. Global Sustained Release Ocular Drug Delivery Systems Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Sustained Release Ocular Drug Delivery Systems Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Company (2020-2022)

Table 19. Global Sustained Release Ocular Drug Delivery Systems Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Company (2020-2022)

Table 21. Global Sustained Release Ocular Drug Delivery Systems Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Producing Area Distribution and Sales Area

Table 23. Players Sustained Release Ocular Drug Delivery Systems Products Offered

Table 24. Sustained Release Ocular Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Sustained Release Ocular Drug Delivery Systems Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Geographic Region (2017-2022)

Table 29. Global Sustained Release Ocular Drug Delivery Systems Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Sustained Release Ocular Drug Delivery Systems Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country/Region (2017-2022)

Table 33. Global Sustained Release Ocular Drug Delivery Systems Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2017-2022)

Table 37. Americas Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2017-2022)

Table 39. Americas Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2022)

Table 41. Americas Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2022)

Table 43. APAC Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2017-2022)

Table 45. APAC Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2017-2022)

Table 47. APAC Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2022)

Table 49. APAC Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2022)

Table 51. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2017-2022)

Table 53. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2017-2022)

Table 55. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2022)

Table 57. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Sustained Release Ocular Drug Delivery Systems

Table 68. Key Market Challenges & Risks of Sustained Release Ocular Drug Delivery Systems

Table 69. Key Industry Trends of Sustained Release Ocular Drug Delivery Systems

Table 70. Sustained Release Ocular Drug Delivery Systems Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Sustained Release Ocular Drug Delivery Systems Distributors List

Table 73. Sustained Release Ocular Drug Delivery Systems Customer List

Table 74. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Sustained Release Ocular Drug Delivery Systems Sales Market Forecast by Region

Table 76. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Sustained Release Ocular Drug Delivery Systems Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Application (2023-2028)

Table 94. pSivida Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 95. pSivida Sustained Release Ocular Drug Delivery Systems Product Offered

Table 96. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. pSivida Main Business

Table 98. pSivida Latest Developments

Table 99. Allergan Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 100. Allergan Sustained Release Ocular Drug Delivery Systems Product Offered

Table 101. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Allergan Main Business

Table 103. Allergan Latest Developments

Table 104. Icon Bioscience Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 105. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Offered

Table 106. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Icon Bioscience Main Business

Table 108. Icon Bioscience Latest Developments

Table 109. Ocular Therapeutix Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 110. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Offered

Table 111. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Ocular Therapeutix Main Business

Table 113. Ocular Therapeutix Latest Developments

Table 114. Neurotech Pharmaceuticals Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 115. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offered

Table 116. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Neurotech Pharmaceuticals Main Business

Table 118. Neurotech Pharmaceuticals Latest Developments

Table 119. Santen Pharmaceutical Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 120. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Offered

Table 121. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Santen Pharmaceutical Main Business

Table 123. Santen Pharmaceutical Latest Developments

Table 124. Aciont Inc. Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 125. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Offered

Table 126. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Aciont Inc. Main Business

Table 128. Aciont Inc. Latest Developments

Table 129. Envisia Therapeutics Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 130. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Offered

Table 131. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. Envisia Therapeutics Main Business

Table 133. Envisia Therapeutics Latest Developments

Table 134. GrayBug Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 135. GrayBug Sustained Release Ocular Drug Delivery Systems Product Offered

Table 136. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. GrayBug Main Business

Table 138. GrayBug Latest Developments

Table 139. Innocore Pharmaceuticals Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 140. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offered

Table 141. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Innocore Pharmaceuticals Main Business

Table 143. Innocore Pharmaceuticals Latest Developments

Table 144. OHR Pharmaceuticals Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 145. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Offered

Table 146. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. OHR Pharmaceuticals Main Business

Table 148. OHR Pharmaceuticals Latest Developments

Table 149. PolyActiva Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 150. PolyActiva Sustained Release Ocular Drug Delivery Systems Product Offered

Table 151. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. PolyActiva Main Business

Table 153. PolyActiva Latest Developments

Table 154. TheraKine Basic Information, Sustained Release Ocular Drug Delivery Systems Manufacturing Base, Sales Area and Its Competitors

Table 155. TheraKine Sustained Release Ocular Drug Delivery Systems Product Offered

Table 156. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 157. TheraKine Main Business

Table 158. TheraKine Latest Developments

List of Figures

Figure 1. Picture of Sustained Release Ocular Drug Delivery Systems

Figure 2. Sustained Release Ocular Drug Delivery Systems Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Sustained Release Ocular Drug Delivery Systems Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Liposome

Figure 10. Product Picture of Microcapsules/Nanocapsules

Figure 11. Product Picture of Microspheres/Nanosptheres

Figure 12. Product Picture of Implants

Figure 13. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2021

Figure 14. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2017-2022)

Figure 15. Sustained Release Ocular Drug Delivery Systems Consumed in Cataract

Figure 16. Global Sustained Release Ocular Drug Delivery Systems Market: Cataract (2017-2022) & (K Pcs)

Figure 17. Sustained Release Ocular Drug Delivery Systems Consumed in Glaucoma

Figure 18. Global Sustained Release Ocular Drug Delivery Systems Market: Glaucoma (2017-2022) & (K Pcs)

Figure 19. Sustained Release Ocular Drug Delivery Systems Consumed in Corneal Transplantation

Figure 20. Global Sustained Release Ocular Drug Delivery Systems Market: Corneal Transplantation (2017-2022) & (K Pcs)

Figure 21. Sustained Release Ocular Drug Delivery Systems Consumed in Others

Figure 22. Global Sustained Release Ocular Drug Delivery Systems Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2022)

Figure 24. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application in 2021

Figure 25. Sustained Release Ocular Drug Delivery Systems Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Company in 2021

Figure 27. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Geographic Region in 2021

Figure 29. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2017-2022)

Figure 30. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country/Region in 2021

Figure 31. Americas Sustained Release Ocular Drug Delivery Systems Sales 2017-2022 (K Pcs)

Figure 32. Americas Sustained Release Ocular Drug Delivery Systems Revenue 2017-2022 ($ Millions)

Figure 33. APAC Sustained Release Ocular Drug Delivery Systems Sales 2017-2022 (K Pcs)

Figure 34. APAC Sustained Release Ocular Drug Delivery Systems Revenue 2017-2022 ($ Millions)

Figure 35. Europe Sustained Release Ocular Drug Delivery Systems Sales 2017-2022 (K Pcs)

Figure 36. Europe Sustained Release Ocular Drug Delivery Systems Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue 2017-2022 ($ Millions)

Figure 39. Americas Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country in 2021

Figure 40. Americas Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country in 2021

Figure 41. United States Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region in 2021

Figure 46. APAC Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Regions in 2021

Figure 47. China Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country in 2021

Figure 54. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country in 2021

Figure 55. Germany Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country in 2021

Figure 62. Egypt Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Sustained Release Ocular Drug Delivery Systems Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Sustained Release Ocular Drug Delivery Systems in 2021

Figure 68. Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems

Figure 69. Industry Chain Structure of Sustained Release Ocular Drug Delivery Systems

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles